Shasun Pharmaceuticals Limited
Records under this name other than patents Shasun Pharmaceuticals Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Shasun Pharmaceuticals Limited
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,028,869 | Modified release ibuprofen dosage form Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,085,939 | Composition of Dexibuprofen Transdermal Hydrogel Formerly held Lapsed on the fee record Ended Oct 2, 2026 · High confidence | Lapsed on the fee record | Ended Oct 2, 2026 | High confidence |
| US 9,730,895 | Method for providing modified release of ibuprofen Formerly held Term ended Term ended Sep 29, 2025 · USPTO record | Term ended | Term ended Sep 29, 2025 | USPTO record |
| US 9,580,414 | Salts and hydrates of antipsychotics Lapsed on the fee record Ended Feb 28, 2021 · USPTO record | Lapsed on the fee record | Ended Feb 28, 2021 | USPTO record |
| US 8,710,154 | Non-aqueous solution process for the preparation of cross-linked polymers Lapsed on the fee record Ended Apr 29, 2018 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2018 | USPTO record |